Idarubicin in acute leukemia: results of US trials.
Berman
E
E
Memorial Sloan-Kettering Cancer Center, New York, NY.
Raymond
V
V
Gee
T S
TS
Kempin
S J
SJ
Gulati
S
S
Andreeff
M
M
Gabrilove
J
J
Young
C W
CW
Clarkson
B D
BD
Wiernik
P H
PH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
D003561:Cytarabine; D015255:Idarubicin; D003630:Daunorubicin